Cited by 65Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project

Open access
McIntyre, Roger S., Woldeyohannes, Hanna O., Soczynska, Joanna K., Vinberg, Maj, Cha, Danielle S., Lee, Yena, Gallaugher, Laura A., Dale, Roman S. +5 more·2016·Therapeutic Advances in Chronic Disease

Abstract

OBJECTIVES: The aim of the study was to evaluate the prevalence of and illness characteristics in adults with major depressive disorder (MDD) with anxious distress specifier (ADS) enrolled in the International Mood Disorders Collaborative Project, which is a collaborative research platform at the Mood Disorders Psychopharmacology Unit, University of Toronto, Canada and the Cleveland Clinic, Cleveland, Ohio, USA. METHODS: Data from participants who met criteria for a current major depressive episode as part of MDD (n = 830) were included in this post hoc analysis. Diagnostic and Statistical Manual Version-5-defined ADS was operationalized as the presence of at least two out of three proxy items instead of two out of five specifiers. RESULTS: A total of 464 individuals (i.e. 56%) met criteria for ADS. There were no between-group differences in sociodemographic variables (e.g. gender, employment, marital status). Greater severity of illness was observed in adults with ADS as evidenced by a higher number of hospitalizations, higher rates of suicidal ideation, greater depressive symptom severity, greater workplace impairment, decreased quality of life, and greater self-reported cognitive impairment. CONCLUSIONS: Our findings underscore the importance of evaluating ADS in adults with MDD as its presence identifies a subpopulation with greater illness-associated burden and hazards.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2040622315627805

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anxious depression defined with the anxious distress specifier was associated with greater depression severity, higher suicidal ideation, decreased quality of life, greater self-reported impairment, severe insomnia, and increased incidence of cardiovascular disease.

    “Also anxious depression defined with the anxious distress specifier was associated with greater depression severity, higher suicidal ideation, decreased QOL, greater self-reported impairment, severe insomnia [10,40], and increased incidence of cardiovascular disease [43].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McIntyre, R. S., Woldeyohannes, H. O., Soczynska, J. K., Vinberg, M., Cha, D. S., Lee, Y., Gallaugher, L. A., Dale, R. S., Alsuwaidan, M. T., Mansur, R. B., Muzina, D. J., Carvalho, A., & Kennedy, S.
Affiliations
  • University Health Network (CA)
  • University of Copenhagen (DK)
  • Cleveland Clinic (US)
  • Medco Health Solutions, Inc., Fort Worth, TX, USA
  • Universidade Federal do Ceará (BR)
  • University of Toronto (CA)
Corresponding author
McIntyre, Roger S.
Venue
Therapeutic Advances in Chronic Disease
Published
2016-02-01
Volume
7
Issue
3
Pages
153-159
ISSN
  • 2040-6223 (ISSN-L)
  • 2040-6231
OpenAlex
W2404889380
Cited by
63
References
7
Citations by year
2026: 5 · 2025: 6 · 2024: 13 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 6 · 2017: 4
FWCI
3.78
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Chronic Disease (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
major depressive disorder, anxiety comorbidity, prevalence, disease severity, suicidal ideation, hospitalization, depression severity, quality of life, cognitive impairment, DSM-5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review